Combining oncolytic HSV-1 with immunogenic cell death-inducing drug mitoxantrone breaks cancer immune tolerance and improves therapeutic efficacy (Q39000548)

From Wikidata
Jump to navigation Jump to search
scientific article published on 19 August 2013
edit
Language Label Description Also known as
English
Combining oncolytic HSV-1 with immunogenic cell death-inducing drug mitoxantrone breaks cancer immune tolerance and improves therapeutic efficacy
scientific article published on 19 August 2013

    Statements

    Combining oncolytic HSV-1 with immunogenic cell death-inducing drug mitoxantrone breaks cancer immune tolerance and improves therapeutic efficacy (English)
    Samuel T Workenhe
    Brian D Lichty
    Derek T Cummings
    19 August 2013
    309-319

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit